RAPT Therapeutics (RAPT) Appoints Lori Lyons-Williams to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
RAPT Therapeutics Appoints Industry Veteran Lori Lyons-Williams to its Board of Directors
November 9, 2021 4:01 PM ESTSOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced the appointment of Lori Lyons-Williams, a 20-year industry veteran, to its Board of Directors.
We are very excited to welcome Lori to RAPTs board of directors, said Brian Wong, M.D., Ph.D., President and CEO of RAPT Therapeutics. Her strong track record of driving strategic and commercial... More
